← Back to JWH-122

JWH-122 Stats & Data

Cannabinoid

NPS DataHub

MW355.48

FormulaC25H25NO

CAS619294-47-2

IUPAC(4-Methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone

SMILESCCCCCN1:C:C(C(=O)c2ccc(C)c3ccccc23)c2ccccc12

Cannabinoids; 2020/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2021/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen; 2022/2.1 Von Indol Pyrazol und 4-Chinolon abgeleitete Verbindungen

Chemical Class Cannabinoid

Tolerance & Pharmacokinetics

drugs.wiki

Tolerance Decay

Full tolerance 3d Half tolerance 21d Baseline ~28d

Experience Report Analysis

Erowid

7 Reports

2010–2014 Date Range

7 With Age Data

5 Effects Detected

Demographics

Gender Distribution

Age Distribution

Reports Over Time

Effect Analysis

Erowid

Effects aggregated from 7 experience reports (7 Erowid)

7 Reports

5 Effects Detected

3 Positive

1 Adverse

1 Neutral

Effect Sentiment Distribution

Confidence Distribution

Positive Effects 3

Euphoria 57.1% 70%

Music Enhancement 42.9% 70%

Tactile Enhancement 42.9% 70%

Adverse Effects 1

Anxiety 57.1% 70%

Real-World Dose Distribution

62K Doses

From 11 individual dose entries

Form / Preparation

Most common forms and preparations reported

Read full reports on Erowid →

← Back to JWH-122